Study aims to cut hospital time after liver surgery by looking beyond medicine
NCT ID NCT01715402
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at 3000 patients having liver surgery to see if considering both medical and social factors could reduce how long they stay in the hospital. Researchers tracked things like complications and readmissions. The goal is to find ways to improve recovery and lower healthcare costs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to shorter hospital stays and lower healthcare costs for liver surgery patients.
- What could go wrong
- This is an observational study, so it won't directly test a new treatment. Results may not apply to all hospitals or patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
3,000 people
The number who actually took part.
- Started
-
Sep 2012
- Finished
-
Sep 2015
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
the population corresponds to patients operated in one of the thirteen hospitals. These hospitals are distributed on the french territory to ensure that the recruitment is representative of the general population
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * elective liver surgery * older than 18 * agreed to participate * surgical procedure included procedures registered as "HLFA003 - 007 ; 009 - 011 ; 017 - 020 ; HLFC002 à 004 ; 027 ; 032 ; 037" in the PMSI database Exclusion Criteria: * emergency surgery * refused to participate
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hepatocellular carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amiens North Hospital
Amiens, France
-
Beaujon University Hospital
Clichy, France
-
Bordeaux Hospital
Bordeaux, France
-
Gustave Roussy institute
Villejuif, France
-
Lille Regional Hospital
Lille, France
-
Lyon Hospital
Lyon, France
-
Marseille Hospital
Marseille, France
-
Paoli calmette institute
Marseille, France
-
Paul Brousse Hospital
Villejuif, France
-
Saint Antoine Hospital
Paris, France
-
Strasbourg hospital
Strasbourg, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sparing the liver: targeted chemoembolization meets lenvatinib in liver cancer
- AI-Enhanced ultrasound aims to catch liver cancer earlier
- Can turbocharged immune cells stop liver cancer from coming back?
- Two blood markers put to the test for early liver cancer detection
- New antibody pair takes aim at advanced liver cancer in major trial
- New antibody aims to preserve immune checkpoint while fighting cancer